Bispecific Antibodies: Downstream Purification - BioProcess InternationalBioProcess International
Purifying bispecific antibodies in a single step | Cytiva
Neutralization activity of IgG antibody in COVID‑19‑convalescent plasma against SARS-CoV-2 variants | Scientific Reports
A Robust Method for the Purification and Characterization of Recombinant Human Histone H1 Variants | Biochemistry
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies | Nature Medicine
Fast Purification of Recombinant Monomeric Amyloid-β from E. coli and Amyloid-β-mCherry Aggregates from Mammalian Cells | ACS Chemical Neuroscience
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants | Nature Communications
Multivalent S2-based vaccines provide broad protection against SARS-CoV-2 variants of concern and pangolin coronaviruses - eBioMedicine
Frontiers | Generation of a symmetrical trispecific NK cell engager based on a two-in-one antibody
BioTech | Free Full-Text | Highly Efficient Purification of Recombinant VSV-∆G-Spike Vaccine against SARS-CoV-2 by Flow-Through Chromatography
Optimized expression and purification of a soluble BMP2 variant based on in-silico design - ScienceDirect
SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization | Nature Communications
Structural conservation among variants of the SARS-CoV-2 spike postfusion bundle | PNAS
Monitoring SARS-CoV-2 variants alterations in Nice neighborhoods by wastewater nanopore sequencing - The Lancet Regional Health – Europe
Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants | Nature Communications
CUTANA™ DNA Purification Kit
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles | PNAS
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity: Molecular Therapy
MAVE-NN: learning genotype-phenotype maps from multiplex assays of variant effect | Genome Biology | Full Text
Self-amplifying mRNA SARS-CoV-2 vaccines raise cross-reactive immune response to variants and prevent infection in animal models: Molecular Therapy - Methods & Clinical Development
Protocol to isolate and assess spike protein cleavage in SARS-CoV-2 variants obtained from clinical COVID-19 samples - ScienceDirect
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy: Molecular Therapy
SARS-CoV-2 Neutralization Assay Kit - The Native Antigen Company
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition - ScienceDirect
SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern | PNAS
Combining an optimized mRNA template with a double purification process allows strong expression of in vitro transcribed mRNA - ScienceDirect
Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants - ScienceDirect
In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential - ScienceDirect
